Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 5 (2008), Issue 3 (March)

1. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.
   Cancer, 112(5): 1106-13. [Abstract] [Full-text]
2. Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells.
   Cancer, 112(5): 1122-30. [Abstract] [Full-text]
3. Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.
   Cancer, 112(5): 1114-21. [Abstract] [Full-text]
4. Genomic instability in patients with non-small cell lung cancer assessed by the arbitrarily primed polymerase chain reaction.
   Cancer Invest, 26(3): 262-8. [Abstract] [Full-text]
5. The role of gefitinib in the management of Asian patients with non-small cell lung cancer.
   Expert Opin Investig Drugs, 17(3): 401-11. [Abstract] [Full-text]
6. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
   Gastroenterology, 134(3): 781-92. [Abstract] [Full-text]
7. Ovarian undifferentiated carcinoma resembling giant cell carcinoma of the lung.
   Pathol Int, 58(4): 244-8. [Abstract] [Full-text]
8. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
   Oncogene, 27(11): 1536-44. [Abstract] [Full-text]
9. Utility of detailed preoperative cardiac testing and incidence of post-thoracotomy myocardial infarction.
   J Thorac Cardiovasc Surg, 135(3): 648-55. [Abstract] [Full-text]
10. Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance.
    J Thorac Cardiovasc Surg, 135(3): 642-7. [Abstract] [Full-text]
11. A simple two-gene prognostic model for adenocarcinoma of the lung.
    J Thorac Cardiovasc Surg, 135(3): 627-34. [Abstract] [Full-text]
12. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    J Thorac Cardiovasc Surg, 135(3): 615-9. [Abstract] [Full-text]
13. Lymph node and pulmonary metastases after transplantation of oral squamous cell carcinoma cell line (HSC-3) into the subcutaneous tissue of nude mouse: detection of metastases by genetic methods using beta-globin and mutant p53 genes.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 105(4): 486-90. [Abstract] [Full-text]
14. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.
    Cancer Genet Cytogenet, 182(1): 1-11. [Abstract] [Full-text]
15. Usefulness of contrast-enhanced magnetic resonance imaging for evaluating solitary pulmonary nodules.
    Cancer Imaging, 8: 36-44. [Abstract] [Full-text]
16. Radiofrequency ablation of pulmonary tumours: current status.
    Cancer Imaging, 8: 27-35. [Abstract] [Full-text]
17. siRNA targeting against EGFR, a promising candidate for a novel therapeutic application to lung adenocarcinoma.
    Pathobiology, 75(1): 2-8. [Abstract] [Full-text]
18. Skin metastasis from typical carcinoid tumor of the lung.
    J Cutan Pathol, 35(4): 418-22. [Abstract] [Full-text]
19. Suppression of non-small cell lung tumor development by the let-7 microRNA family.
    Proc Natl Acad Sci U S A, 105(10): 3903-8. [Abstract] [Full-text]
20. Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy.
    Jpn J Clin Oncol, 38(3): 214-21. [Abstract] [Full-text]
21. DNA methylation markers and early recurrence in stage I lung cancer.
    N Engl J Med, 358(11): 1118-28. [Abstract] [Full-text]
22. Dietary genistein inhibits metastasis of human prostate cancer in mice.
    Cancer Res, 68(6): 2024-32. [Abstract] [Full-text]
23. Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice.
    Cancer Res, 68(6): 1896-904. [Abstract] [Full-text]
24. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.
    Cancer Res, 68(6): 1707-14. [Abstract] [Full-text]
25. Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.
    Cancer Res, 68(6): 1647-55. [Abstract] [Full-text]
26. Lung cancer masquerading as prosthetic valve endocarditis.
    Heart Lung Circ, 17(2): 161-3. [Abstract] [Full-text]
27. Case report: Second primary small cell carcinoma of the trachea in a breast cancer survivor: a case report and literature review.
    Br J Radiol, 81(964): e120-2. [Abstract] [Full-text]
28. Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.
    Mol Pharmacol, 73(4): 1290-300. [Abstract] [Full-text]
29. Use of bioluminescence imaging to detect enhanced hepatic and systemic tumor growth following partial hepatectomy in mice.
    Eur J Surg Oncol, 34(4): 476-81. [Abstract] [Full-text]
30. A small mammal model of tumour implantation, dissemination and growth factor expression after partial hepatectomy.
    Eur J Surg Oncol, 34(4): 469-75. [Abstract] [Full-text]
31. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Neurology, 70(12): 924-8. [Abstract] [Full-text]
32. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
    J Clin Oncol, 26(9): 1472-8. [Abstract] [Full-text]
33. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
    J Clin Oncol, 26(9): 1459-64. [Abstract] [Full-text]
34. Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer.
    J Clin Oncol, 26(9): 1452-8. [Abstract] [Full-text]
35. The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer.
    Clin Pharmacol Ther, 83(4): 589-94. [Abstract] [Full-text]
36. Effects of talc dust on respiratory health: results of a longitudinal survey of 378 French and Austrian talc workers.
    Occup Environ Med, 65(4): 261-7. [Abstract] [Full-text]
37. Occupational lung cancer risk among men in the Netherlands.
    Occup Environ Med, 65(4): 249-54. [Abstract] [Full-text]
38. Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib.
    Pharmacogenomics J, 8(2): 129-38. [Abstract] [Full-text]
39. Pseudocavitating bronchioloalveolar carcinoma followed over a decade.
    Ann Thorac Surg, 85(4): 1432-4. [Abstract] [Full-text]
40. Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.
    Ann Thorac Surg, 85(4): 1430-2. [Abstract] [Full-text]
41. Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma model.
    Ann Thorac Surg, 85(4): 1225-32. [Abstract] [Full-text]
42. Carinaplasty airway closure: a technique for right pneumonectomy.
    Ann Thorac Surg, 85(4): 1178-85; discussion 1185-6. [Abstract] [Full-text]
43. Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?
    Ann Thorac Surg, 85(4): 1166-9; discussion 1169-70. [Abstract] [Full-text]
44. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer.
    Am J Respir Crit Care Med, 177(7): 763-70. [Abstract] [Full-text]
45. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening.
    Thorax, 63(4): 377-83. [Abstract] [Full-text]
46. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.
    Thorax, 63(4): 352-9. [Abstract] [Full-text]
47. Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.
    Ann Oncol, 19(4): 739-45. [Abstract] [Full-text]
48. Telomerase activity in transthoracic fine needle biopsy aspirates as a marker of peripheral lung cancer.
    Thorax, 63(4): 342-4. [Abstract] [Full-text]
49. Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lymphoma.
    Thorax, 63(4): 360-5. [Abstract] [Full-text]
50. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules.
    Thorax, 63(4): 335-41. [Abstract] [Full-text]
51. Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway.
    Oncogene, 27(14): 1981-92. [Abstract] [Full-text]
52. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer.
    Acta Radiol, 49(3): 295-302. [Abstract] [Full-text]
53. Noninvasive diagnosis of bronchial artery aneurysm using dual-source computed tomography angiography.
    Acta Radiol, 49(3): 291-4. [Abstract] [Full-text]
54. Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions.
    Histopathology, 52(5): 613-22. [Abstract] [Full-text]
55. Phase II study of a 3-week schedule of irinotecan combined with cisplatin in previously untreated extensive-stage small-cell lung cancer.
    Oncology, 73(1): 76-80. [Abstract] [Full-text]
56. Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment.
    J Heart Lung Transplant, 27(4): 462-5. [Abstract] [Full-text]
57. Remediastinoscopy in restaging of lung cancer after induction therapy.
    J Thorac Cardiovasc Surg, 135(4): 843-9. [Abstract] [Full-text]
58. Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of the lung.
    J Thorac Cardiovasc Surg, 135(4): 830-6. [Abstract] [Full-text]
59. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    J Thorac Cardiovasc Surg, 135(4): 816-22. [Abstract] [Full-text]
60. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Arch Phys Med Rehabil, 89(4): 595-601. [Abstract] [Full-text]
61. Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis.
    J Clin Pathol, 61(4): 487-93. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.